Research ArticleClinical Studies

Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection

CHRISTOPHER MÅNSSON, ANDERS NILSSON, PETER NYGREN and BRITT-MARIE KARLSON
Anticancer Research May 2020, 40 (5) 2771-2775; DOI: https://doi.org/10.21873/anticanres.14249

Article Information

vol. 40 no. 5 2771-2775
DOI 
https://doi.org/10.21873/anticanres.14249
PMID 
32366423
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 15, 2020
  • Revision received March 29, 2020
  • Accepted March 31, 2020
  • Published online May 4, 2020.
Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. CHRISTOPHER MÅNSSON1⇑,
  2. ANDERS NILSSON1,
  3. PETER NYGREN2 and
  4. BRITT-MARIE KARLSON1
  1. 1Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  2. 2Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
  1. Correspondence to: Christopher Månsson, Department of Surgical Sciences, Uppsala University, 75185 Uppsala, Sweden. Tel: +46 186114505, Fax: +46 186114508, e-mail: christopher.mansson{at}surgsci.uu.se
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection
CHRISTOPHER MÅNSSON, ANDERS NILSSON, PETER NYGREN, BRITT-MARIE KARLSON
Anticancer Research May 2020, 40 (5) 2771-2775; DOI: 10.21873/anticanres.14249
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords